e-learning
resources
Virtual 2021
06.09.2021
Respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores
V. Ueckermann (Pretoria (Gauteng), South Africa), M. Ehlers (Pretoria (Gauteng), South Africa)
Source:
Virtual Congress 2021 – Respiratory infections
Session:
Respiratory infections
Session type:
Oral Presentation
Number:
1662
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Ueckermann (Pretoria (Gauteng), South Africa), M. Ehlers (Pretoria (Gauteng), South Africa). Late Breaking Abstract - Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores. 1662
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Late Breaking Abstract - Protein signature stratifies severity of chronic lung disease in preterms after birth
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Late Breaking Abstract - Impact of increasing notification thresholds for remote respiratory monitoring in patients with chronic lung disease
Source: Virtual Congress 2021 – E-health for COVID-19
Year: 2021
Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Anaemia in COPD: mortality and disease severity
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology.
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Late Breaking Abstract - Pneumonectomy in patients with reduced pulmonary function: complications and 30-day mortality
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Late Breaking Abstract - Economics burden and healthcare utilization in chronic obstructive pulmonary disease patients with or without sepsis.
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Frailty in chronic respiratory disease: prevalence and comparison of rehabilitation clinical outcomes
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients
Source: Eur Respir J 2011; 38: 643-648
Year: 2011
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Mortality: a neglected outcome in OCS-treated severe asthma
Source: Eur Respir J, 50 (5) 1701486; 10.1183/13993003.01486-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept